Mantle Cell Lymphoma in the Thyroid: A Rare Presentation

Table 1

Comparing our patient to another 2 cases reported in literature.

	Our patient	Hojilla et al. [9]; (2016)	Guastafierro et al. [10]; (2010)
Age of patient at diagnosis	63	59	59
Presence of Hashimoto’s thyroiditis	Present	Presence of hypothyroidism	Present
Stage of disease	Stage II EA	?	Stage I EA
Location of distant metastases	None	Involvement of colon	?
Ki-67 index	10%; (lymph node)	10–15%; (in the colon)	>30%
Treatment	Surveillance	Surveillance	8 courses of R-CEOP (rituximab-cyclophosphamide, epirubicin, vincristine, and prednisone), followed by rituximab for 2 years
Survival until publication	Progression-free for 2 years	Progression-free for 2 years	Relapse-free for 4 years